Exchange: NASDAQ·Updated 04:10 PM EDT
EVMN logo

EVMN Evommune Inc

$12.27
$0.27
(2.25%)
Today
Closed $12.27
$0.00
(0.00%)
After Hours
Mkt Cap$435.51M
Vol249,081.00

About EVMN

Evommune, Inc. is a clinical-stage biotechnology company. It engages in the development of medicines for inflammatory diseases. The company was founded by Luis C. Pena, Eugene Andrew Bauer, and Hans Hofland in 2020 and is headquartered in Palo Alto, CA.
59

Bullish Sentiment

How do you feel about EVMN?

Advertisement|Remove ads.